Back to
ABN AMRO Bank N.V.
VRTX14 quarters
Position history for
ABN AMRO Bank N.V.'s holdings in VERTEX PHARMACEUTICALS INC
Yes. ABN AMRO Bank holds 125,970 shares of VRTX (Vertex Pharmaceuticals), worth $62.5M, as of its Q2 2026 13F filing. It increased the position by 7,621 shares (+6.4%) from Q1 2026. ABN AMRO Bank has held VRTX in every 13F on record since Q1 2023, 14 quarterly filings. VRTX is 0.8% of ABN AMRO Bank's reported 13F portfolio.
Current Value
$62.5M
Current Shares
125,970
Total Value Change
+$33.2M
Total Shares Change
+32,976
Quarter-by-Quarter History
Other major holders of VRTX: BNP PARIBAS FINANCIAL MARKETS, Capital World Investors